• Something wrong with this record ?

Decreased exercise capacity and sleep-disordered breathing in patients with hypertrophic cardiomyopathy

T Konecny, JB Geske, O Ludka, M Orban, PA Brady, MM Abudiab, FN Albuquerque, A Placek, T Kara, KR Sahakyan, BJ Gersh, AJ Tajik, TG Allison, SR Ommen, VK Somers

. 2015 ; 147 (6) : 1574-1581.

Language English Country United States

Persistent link   https://www.medvik.cz/link/bmc19029779

Grant support
NT11401 MZ0 CEP Register

BACKGROUND: Mechanisms of decreased exercise capacity in patients with hypertrophic cardiomyopathy (HCM) are not well understood. Sleep-disordered breathing (SDB) is a highly prevalent but treatable disorder in patients with HCM. The role of comorbid SDB in the attenuated exercise capacity in HCM has not been studied previously. METHODS: Overnight oximetry, cardiopulmonary exercise testing, and echocardiographic studies were performed in consecutive patients with HCM seen at the Mayo Clinic. SDB was considered present if the oxygen desaturation index (number of >= 4% desaturations/h) was >= 10. Peak oxygen consumption (VO2 peak) (the most reproducible and prognostic measure of cardiovascular fitness) was then correlated with the presence and severity of SDB. RESULTS: A total of 198 patients with HCM were studied (age, 53 +/- 16 years; 122 men), of whom 32% met the criteria for the SDB diagnosis. Patients with SDB had decreased VO2 peak compared with those without SDB (16 mL O2/kg/min vs 21 mL O2/kg/min, P < .001). SDB remained significantly associated with VO2 peak after accounting for confounding clinical variables (P < .001) including age, sex, BMI, atrial fibrillation, and coronary artery disease. CONCLUSIONS: In patients with HCM, the presence of SDB is associated with decreased VO2 peak. SDB may represent an important and potentially modifiable contributor to impaired exercise tolerance in this unique population.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19029779
003      
CZ-PrNML
005      
20220411124205.0
007      
ta
008      
190821s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1378/chest.14-1498 $2 doi
035    __
$a (PubMed)25633371
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Konečný, Tomáš $7 _AN082784 $u Konecny, Tomas. Mayo Clinic, Rochester, MN; St. Anne's University Hospital, International Clinical Research Center (ICRC), Brno, Czech Republic.
245    10
$a Decreased exercise capacity and sleep-disordered breathing in patients with hypertrophic cardiomyopathy / $c T Konecny, JB Geske, O Ludka, M Orban, PA Brady, MM Abudiab, FN Albuquerque, A Placek, T Kara, KR Sahakyan, BJ Gersh, AJ Tajik, TG Allison, SR Ommen, VK Somers
520    9_
$a BACKGROUND: Mechanisms of decreased exercise capacity in patients with hypertrophic cardiomyopathy (HCM) are not well understood. Sleep-disordered breathing (SDB) is a highly prevalent but treatable disorder in patients with HCM. The role of comorbid SDB in the attenuated exercise capacity in HCM has not been studied previously. METHODS: Overnight oximetry, cardiopulmonary exercise testing, and echocardiographic studies were performed in consecutive patients with HCM seen at the Mayo Clinic. SDB was considered present if the oxygen desaturation index (number of >= 4% desaturations/h) was >= 10. Peak oxygen consumption (VO2 peak) (the most reproducible and prognostic measure of cardiovascular fitness) was then correlated with the presence and severity of SDB. RESULTS: A total of 198 patients with HCM were studied (age, 53 +/- 16 years; 122 men), of whom 32% met the criteria for the SDB diagnosis. Patients with SDB had decreased VO2 peak compared with those without SDB (16 mL O2/kg/min vs 21 mL O2/kg/min, P < .001). SDB remained significantly associated with VO2 peak after accounting for confounding clinical variables (P < .001) including age, sex, BMI, atrial fibrillation, and coronary artery disease. CONCLUSIONS: In patients with HCM, the presence of SDB is associated with decreased VO2 peak. SDB may represent an important and potentially modifiable contributor to impaired exercise tolerance in this unique population.
590    __
$a bohemika - dle Pubmed
650    02
$a dospělí $7 D000328
650    02
$a senioři $7 D000368
650    12
$a hypertrofická kardiomyopatie $x epidemiologie $x patofyziologie $7 D002312
650    02
$a komorbidita $7 D015897
650    02
$a průřezové studie $7 D003430
650    02
$a zátěžový test $7 D005080
650    12
$a tolerance zátěže $x fyziologie $7 D017079
650    02
$a ženské pohlaví $7 D005260
650    02
$a srdeční frekvence $x fyziologie $7 D006339
650    02
$a lidé $7 D006801
650    02
$a mužské pohlaví $7 D008297
650    02
$a lidé středního věku $7 D008875
650    02
$a oxymetrie $7 D010092
650    02
$a spotřeba kyslíku $x fyziologie $7 D010101
650    02
$a prevalence $7 D015995
650    02
$a stupeň závažnosti nemoci $7 D012720
650    12
$a spánková apnoe centrální $7 D020182
650    02
$a tepový objem $x fyziologie $7 D013318
700    1_
$a Geske JB
700    1_
$a Ludka, Ondřej $7 xx0041406
700    1_
$a Orban M
700    1_
$a Brady PA
700    1_
$a Abudiab MM
700    1_
$a Albuquerque FN
700    1_
$a Placek A
700    1_
$a Kara T
700    1_
$a Sahakyan KR
700    1_
$a Gersh BJ
700    1_
$a Tajik AJ
700    1_
$a Allison TG
700    1_
$a Ommen SR
700    1_
$a Somers VK
773    0_
$t Chest $g Roč. 147, č. 6 (2015), s. 1574-1581 $p Chest $x 0012-3692 $w MED00002127
773    0_
$p Chest $g 147(6):1574-1581, 2015 Jun
910    __
$a ABA008 $b sig $y 4 $z 0
990    __
$a 20190821095735 $b ABA008
991    __
$a 20220411124203 $b ABA008
999    __
$a ok $b bmc $g 1436237 $s 1068252
BAS    __
$a 3
BMC    __
$a 2015 $b 147 $c 6 $d 1574-1581 $x MED00002127 $i 0012-3692 $m Chest
GRA    __
$a NT11401 $p MZ0
LZP    __
$a NLK 2019/lp

Find record

Citation metrics

Archiving options